Dose-dependent cochlear and vestibular toxicity of trans-tympanic cisplatin in the rat

Boadas-Vaello, 2005, Behavioral and pathological effects in the rat define two groups of neurotoxic nitriles, Toxicol. Sci., 88, 456, 10.1093/toxsci/kfi314 Bokemeyer, 1998, Analysis of risk factors for cisplatin-induced ototoxicity in patients with testicular cancer, Br. J. Cancer, 77, 1355, 10.1038/bjc.1998.226 Brugeaud, 2007, Control of hair cell excitability by vestibular primary sensory neurons, J. Neurosci., 27, 3503, 10.1523/JNEUROSCI.5185-06.2007 Callejo, 2015, Cisplatin-induced ototoxicity: effects, mechanisms and protection strategies, Toxics, 3, 268, 10.3390/toxics3030268 Caston, 1987, Comparative vestibular toxicity of dibekacin, habekacin and cisplatin, Acta Otolaryngol., 104, 315, 10.3109/00016488709107334 Chan, 2007, Protection against cisplatin-induced ototoxicity by adeno-associated virus-mediated delivery of the X-linked inhibitor of apoptosis protein is not dependent on caspase inhibition, Otol. Neurotol., 28, 417, 10.1097/01.mao.0000247826.28893.7a Cunningham, 2006, Heat shock inhibits both aminoglycoside- and cisplatin-induced sensory hair cell death, J. Assoc. Res. Otolaryngol., 7, 299, 10.1007/s10162-006-0043-x Ding, 2012, Review: ototoxic characteristics of platinum antitumor drugs, Anat. Rec., 295, 1851, 10.1002/ar.22577 Dyhrfjeld-Johnsen, 2013, Ondansetron reduces lasting vestibular deficits in a model of severe peripheral excitotoxic injury, J. Vestib. Res., 23, 177, 10.3233/VES-130483 Flores-Otero, 2007, Reciprocal regulation of presynaptic and postsynaptic proteins in bipolar spiral ganglion neurons by neurotrophins, J. Neurosci., 27, 14023, 10.1523/JNEUROSCI.3219-07.2007 Gaboyard-Niay, 2016, Correlation between afferent rearrangements and behavioral deficits after local excitotoxic insult in the mammalian vestibule: a rat model of vertigo symptoms, Dis. Model. Mech., 9, 1181, 10.1242/dmm.024521 Golub, 2012, Hair cell replacement in adult mouse utricles after targeted ablation of hair cells with diphtheria toxin, J. Neurosci., 32, 15093, 10.1523/JNEUROSCI.1709-12.2012 Goycoolea, 1997, Round window membrane. Structure function and permeability: a review, Microsc. Res. Tech., 36, 201, 10.1002/(SICI)1097-0029(19970201)36:3<201::AID-JEMT8>3.0.CO;2-R Grewal, 2010, Auditory late effects of childhood cancer therapy: a report from the Children’s Oncology Group, Pediatrics, 125, e938, 10.1542/peds.2009-1597 Gurney, 2007, Hearing loss, quality of life, and academic problems in long-term neuroblastoma survivors: a report from the Children’s Oncology Group, Pediatrics, 120, e1229, 10.1542/peds.2007-0178 He, 2009, Effectiveness of different approaches for establishing cisplatin-induced cochlear lesions in mice, Acta Otolaryngol., 129, 1359, 10.3109/00016480902856604 Janning, 1998, Experimental model of cisplatin ototoxicity in chinchillas, Otolaryngol. Head Neck Surg., 119, 574, 10.1016/S0194-5998(98)70014-2 King, 2013, Gentamicin administration on the stapes footplate causes greater hearing loss and vestibulotoxicity than round window administration in guinea pigs, Hear. Res., 304, 159, 10.1016/j.heares.2013.07.013 Kirkim, 2014, Is there a gender-related susceptibility for cisplatin ototoxicity?, Eur. Arch. Otorhinolaryngol., 2755 Kitsigianis, 1988, Active head-movement analysis of cisplatin-induced vestibulotoxicity, Otolaryngol. Head Neck Surg., 98, 82, 10.1177/019459988809800114 Kobayashi, 1987, Clinical features of cisplatin vestibulotoxicity and hearing loss, ORL J. Otorhinolaryngol. Relat. Spec., 49, 67, 10.1159/000275909 Korver, 2002, Round window application of D-methionine provides complete cisplatin otoprotection, Otolaryngol. Head Neck Surg., 126, 683, 10.1067/mhn.2002.125299 Langer, 2013, Understanding platinum-induced ototoxicity, Trends Pharmacol. Sci., 34, 458, 10.1016/j.tips.2013.05.006 Laurell, 1991, Dose-dependent inner ear changes after i.v. administration of cisplatin, J. Otolaryngol., 20, 158 Li, 2011, Co-administration of cisplatin and furosemide causes rapid and massive loss of cochlear hair cells in mice, Neurotox. Res., 20, 307, 10.1007/s12640-011-9244-0 Llorens, 1997, Comparison of behavioral, vestibular, and axonal effects of subchronic IDPN in the rat, Neurotoxicol. Teratol., 19, 117, 10.1016/S0892-0362(96)00216-4 Llorens, 1993, The behavioral syndrome caused by 3,3′-iminodipropionitrile and related nitriles in the rat is associated with degeneration of the vestibular sensory hair cells, Toxicol. Appl. Pharmacol., 123, 199, 10.1006/taap.1993.1238 Lo, 2015, Assessment of D-methionine protecting cisplatin-induced otolith toxicity by vestibular-evoked myogenic potential tests, ATPase activities and oxidative state in guinea pigs, Neurotoxicol. Teratol., 51, 12, 10.1016/j.ntt.2015.07.004 Madasu, 1997, Ototoxic effects of supradose cisplatin with sodium thiosulfate neutralization in patients with head and neck cancer, Arch. Otolaryngol. Head Neck Surg., 123, 978, 10.1001/archotol.1997.01900090094014 Madias, 1978, Platinum nephrotoxicity, Am. J. Med., 65, 307, 10.1016/0002-9343(78)90825-2 Miller, 2014, Intratympanic Therapies for Menière’s disease, Curr. Otorhinolaryngol. Rep., 2, 137, 10.1007/s40136-014-0055-8 Minami, 2004, Antioxidant protection in a new animal model of cisplatin-induced ototoxicity, Hear. Res., 198, 137, 10.1016/j.heares.2004.07.016 Mukherjea, 2011, NOX3 NADPH oxidase couples transient receptor potential vanilloid 1 to signal transducer and activator of transcription 1-mediated inflammation and hearing loss, Antioxid. Redox Signal., 14, 999, 10.1089/ars.2010.3497 Myers, 1993, Is cis-platinum vestibulotoxic?, Otolaryngol. Head Neck Surg., 108, 322, 10.1177/019459989310800403 Nair, 2016, Simple practice guide for dose conversion between animals and human, J. Basic Clin. Pharm., 7, 27, 10.4103/0976-0105.177703 Nakayama, 1996, Quantitative study of vestibulotoxicity induced by gentamicin or cisplatin in the guinea pig, Laryngoscope, 106, 162, 10.1097/00005537-199602000-00011 Plontke, 2008, Dexamethasone concentration gradients along scala tympani after application to the round window membrane, Otol. Neurotol., 29, 401, 10.1097/MAO.0b013e318161aaae Prim, 2001, Vestibular and oculomotor changes in subjects treated with cisplatin, Acta Otorrinolaringol. Esp., 52, 367, 10.1016/S0001-6519(01)78222-2 Rúa, 2013, Vestibulotoxic properties of potential metabolites of allylnitrile, Toxicol. Sci., 135, 182, 10.1093/toxsci/kft127 Ruggiero, 2013, Platinum compounds in children with cancer: toxicity and clinical management, Anticancer Drugs, 24, 1007, 10.1097/CAD.0b013e3283650bda Rybak, 2007, Mechanisms of cisplatin ototoxicity and progress in otoprotection, Curr. Opin. Otolaryngol. Head Neck Surg., 15, 364, 10.1097/MOO.0b013e3282eee452 Saldaña-Ruíz, 2013, Reduced systemic toxicity and preserved vestibular toxicity following co-treatment with nitriles and CYP2E1 inhibitors: a mouse model for hair cell loss, J. Assoc. Res. Otolaryngol., 14, 661, 10.1007/s10162-013-0399-7 Salt, 2009, Principles of local drug delivery to the inner ear, Audiol. Neurootol., 14, 350, 10.1159/000241892 Schacht, 2012, Cisplatin and aminoglycoside antibiotics: hearing loss and its prevention, Anat. Rec. (Hoboken), 295, 1837, 10.1002/ar.22578 Schaefer, 1981, Cis-platinum vestibular toxicity, Cancer, 47, 857, 10.1002/1097-0142(19810301)47:5<857::AID-CNCR2820470508>3.0.CO;2-M Schmitt, 2009, Cisplatin-induced hair cell death requires STAT1 and is attenuated by epigallocatechin gallate, J. Neurosci., 29, 3843, 10.1523/JNEUROSCI.5842-08.2009 Schweitzer, 1986, Vestibular morphological analysis of the effects of cisplatin vs. platinum analogs, CBDCA (JM-8) and CHIP (JM-9), Laryngoscope, 96, 959, 10.1288/00005537-198609000-00006 Seoane, 2003, Distal effects in a model of proximal axonopathy: 3,3′-iminodipropionitrile causes specific loss of neurofilaments in rat vestibular afferent endings, Acta Neuropathol., 106, 458, 10.1007/s00401-003-0744-8 Sera, 1987, Morphological changes in the vestibular epithelia and ganglion induced by ototoxic drug, Scanning Microsc., 1, 1191 Sergi, 2003, Cisplatin ototoxicity in the guinea pig: vestibular and cochlear damage, Hear. Res., 182, 56, 10.1016/S0378-5955(03)00142-4 Soler-Martín, 2014, Chronic proximal axonopathy in rats is associated with long-standing neurofilament depletion in neuromuscular junctions and behavioral deficits, J. Neuropathol. Exp. Neurol., 73, 568, 10.1097/NEN.0000000000000079 Strauss, 1983, Cis-platinum ototoxicity: clinical experience and temporal bone histopathology, Laryngoscope, 93, 1554, 10.1288/00005537-198312000-00007 Tian, 2013, A combination of cilostazol and Ginkgo biloba extract protects against cisplatin-induced Cochleo-vestibular dysfunction by inhibiting the mitochondrial apoptotic and ERK pathways, Cell. Death Dis., 4, e509, 10.1038/cddis.2013.33 Tofthagen, 2012, Falls in persons with chemotherapy-induced peripheral neuropathy, Support. Care Cancer, 20, 583, 10.1007/s00520-011-1127-7 Vignaux, 2012, Evaluation of the chemical model of vestibular lesions induced by arsanilate in rats, Toxicol. Appl. Pharmacol., 258, 61, 10.1016/j.taap.2011.10.008 Wang, 2003, Local application of sodium thiosulfate prevents cisplatin-induced hearing loss in the guinea pig, Neuropharmacology, 45, 380, 10.1016/S0028-3908(03)00194-1 Whitworth, 2004, Protection against cisplatin ototoxicity by adenosine agonists, Biochem. Pharmacol., 67, 1801, 10.1016/j.bcp.2004.01.010 Wright, 1982, Inner ear histopathology in patients treated with cis-platinum, Laryngoscope, 92, 1408, 10.1288/00005537-198212000-00013 Xia, 2012, Ototoxicity of cisplatin administered to guinea pigs via the round window membrane, J. Toxicol. Sci., 37, 823, 10.2131/jts.37.823 Zhang, 2003, Pifithrin-α supresses p53 and protects cochlear and vestibular hair cells from cisplatin-induced apoptosis, Neuroscience, 120, 191, 10.1016/S0306-4522(03)00286-0 Zou, 2013, Enhanced oval window and blocked round window passages for middle-inner ear transportation of gadolinium in guinea pigs with a perforated round window membrane, Eur. Arch. Otorhinolaryngol.